Privacy versus public health: The impact of current confidentiality rules

American Journal of Public Health

Volumn 100, Issue 3, 2010, Pages 407-412

  Wartenberg, Daniel ^a   Thompson, W Douglas ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; COMPUTER SECURITY; CONFIDENTIALITY; EPIDEMIOLOGY; ETHICS; FACTUAL DATABASE; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LEGAL ASPECT; MEDICAL RECORD; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PRIVACY; PUBLIC HEALTH; RESEARCH; UNITED STATES; VITAL STATISTICS;

ACCESS TO INFORMATION; COMPUTER SECURITY; CONFIDENTIALITY; DATABASES, FACTUAL; EPIDEMIOLOGIC STUDIES; HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT; HEALTH POLICY; HUMANS; MEDICAL RECORDS; POPULATION SURVEILLANCE; PRIVACY; PUBLIC HEALTH; RESEARCH; UNITED STATES; VITAL STATISTICS;

EID: 77149164762     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.166249     Document Type: Review

References (62)

1. Institutional Review Board Guidebook. Glossary. Available at: http://www.hhs.gov/ohrp/irb/irb-glossary.htm. Accessed December 13, 2009.
2. US Dept of Health and Human Services. The privacy rule. Available at: http://www.hhs.gov/ocr/privacy/hipaa/administrative/privacyrule/index.html. Accessed December 13, 2009.
3. Committee on Health Research and the Privacy of Health Information. Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research. Washington, DC: Institute of Medicine; 2009.
4. Nelson KE. Early History of Infectious Disease: Epidemiology and Control of Infectious Diseases. Boston, MA: Jones and Bartlett Publishers; 2005.
5. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer, World Health Organization. Available at: http://monographs.iarc.fr. Accessed December 13, 2009.
6. Dawber TR, Kannel WB. The Framingham Study. An epidemiological approach to coronary heart disease. Circulation. 1966;34(4):553-555.
7. National Center for Health Statistics. Health, United States, 2007, With Chartbook on Trends in the Health of Americans. Hyattsville, MD: US Dept of Health and Human Services; 2007.
8. Institutional Review Board Guidebook. Introduction. Available at: http:// www.hhs.gov/ohrp/irb/irb-introduction.htm. Accessed December 13, 2009.
9. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
10. Tracking Healthy People 2010. Washington, DC: US Dept of Health and Human Services; 2000.
11. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: US Dept of Health and Human Services; 2000. Report 017-001-001-00-550-9.
12. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001; 286(10):1195-1200.
13. Elliott P, Wartenberg D. Spatial epidemiology: current approaches and future challenges. Environ Health Perspect. 2004;112(9):998-1006.
14. Snow J. Snow on Cholera. New York, NY: Hafner; 1965.
15. Mason TJ. Cancer mortality in US counties with plastics and related industries. Environ Health Perspect. 1975; 11:79-84.
16. Schwartz J, Dockery DW. Increased mortality in Philadelphia associated with daily air pollution concentrations. Am Rev Respir Dis. 1992;145(3):600-604.
17. Forastiere F, Stafoggia M, Tasco C, et al. Socioeconomic status, particulate air pollution, and daily mortality: differential exposure or differential susceptibility. Am J Ind Med. 2007;50(3):208-216.
18. Ito K, De Leon SF, Lippmann M, Ito K, De Leon SF, Lippmann M. Associations between ozone and daily mortality: analysis and meta-analysis [see comment]. Epidemiology. 2005;16(4):446-457.
19. Ostro B, Feng WY, Broadwin R, et al. The effects of components of fine particulate air pollution on mortality in California: results from CALFINE. Environ Health Perspect. 2007;115(1):13-19.
20. Gregorio DI, Kulldorff M, Barry L, Samociuk H. Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95. Int J Cancer. 2002;100(2):194-198.
21. Roche LM, Skinner R, Weinstein RB. Use of a geographic information system to identify and characterize areas with high proportions of distant stage breast cancer. J Public Health Manag Pract. 2002;8(2): 26-32.
22. Rothman KJ. The epidemiologist's lament. Am J Public Health. 1981;71(12): 1309-1311.
23. Hershey N. Putting the lamentations of epidemiologists into perspective. Am J Public Health. 1982;72(10):1155-1157.
24. Beebe GW. Long-term follow-up is a problem. Am J Public Health. 1983;73 (3):245-246.
25. Centers for Disease Control and Prevention. The National Death Index. Available at: http://www.cdc.gov/nchs/ndi.htm. Accessed December 13, 2009.
26. Wartenberg D, Agamennone VJ, Ozonoff D, Berry RJ. A microcomputerbased vital records database with interactive graphic assessment for states and localities. Am J Public Health. 1989;79(11): 1531-1536.
27. Paulu C, Ozonoff D, Coogan P, Wartenberg D. Making environmental data accessible for public health aims: The Massachusetts Environmental Database Project. Public Health Rep. 1995;110(6): 776-783.
28. Buehler JW, Berkelman RL, Hartley DM, Peters CJ. Syndromic surveillance and bioterrorism-related epidemics [see comment]. Emerg Infect Dis. 2003;9(10): 1197-1204.
29. Hauenstein L, Gao T, Sze TW, Crawford D, Alm A, White D. A crossfunctional service-oriented architecture to support real-time information exchange in emergency medical response. Conf Proc IEEE Eng Med Biol Soc. September 2006;(suppl):6478-6481.
30. Gesteland PH, Gardner RM, Tsui F-C, et al. Automated syndromic surveillance for the 2002 Winter Olympics. J Am Med Inform Assoc. 2003;10(6): 547-554.
31. Heffernan R, Mostashari F, Das D, et al. New York City syndromic surveillance systems. MMWR Morb Mortal Wkly Rep. 2004;53(suppl):23-27.
32. National Center for Health Statistics. NCHS data release and access policy for micro-data and compressed vital statistics files.Available at:http://www.cdc.gov/nchs/about/major/dvs/NCHS-DataRelease.htm. Accessed December 13, 2009.
33. National Cancer Institute. Surveillance, Epidemiology and End Results. Available at: http://www.seer.cancer.gov.Accessed December 13, 2009.
34. Pope CA 3rd, Dockery DW, Spengler JD, Raizenne ME. Respiratory health and PM10 pollution. A daily time series analysis. Am Rev Respir Dis. 1991;144(3 pt 1):668-674.
35. Pope CA 3rd, Schwartz J, Ransom MR. Daily mortality and PM10 pollution in Utah Valley. Arch Environ Health. 1992;47(3):211-217.
36. Dockery DW, Schwartz J, Spengler JD. Air pollution and daily mortality: associations with particulates and acid aerosols. Environ Res. 1992;59(2):362-373.
37. Schwartz J. Air pollution and daily mortality: a review and meta analysis. Environ Res. 1994;64(1):36-52.
38. Thurston GD, Bekkedal MYV, Roberts EM, et al. Use of health information in air pollution health research: past successes and emerging needs. J Expo Anal Environ Epidemiol. 2009; 19(1):45-58.
39. Samet JM. Particulate air pollution and mortality: the Philadelphia story. Epidemiology. 1995;6(5):471-473.
40. Sram RJ, Binkova B, Dejmek J, Bobak M. Ambient air pollution and pregnancy outcomes: a review of the literature. Environ Health Perspect. 2005; 113(4):375-382.
41. Buczynska A, Tarkowski S. Environmental exposure and birth outcomes. Int J Occup Med Environ Health. 2005; 18(3):225-232.
42. Perera FP, Rauh V, Whyatt RM, et al. A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology. 2005;26(4):573-587.
43. Silbergeld EK, Patrick TE. Environmental exposures, toxicologic mechanisms, and adverse pregnancy outcomes. Am J Obstet Gynecol. 2005;192(5 suppl): S11-S21.
44. Glinianaia SV, Rankin J, Bell R, Pless-Mulloli T, Howel D. Particulate air pollution and fetal health: a systematic review of the epidemiologic evidence. Epidemiology. 2004;15(1):36-45.
45. Booth VL, Shendell DG. Potential health effects associated with residential proximity to freeways and primary roads: review of scientific literature, 1999-2006. J Environ Health. 2008;70(8):33-41.
46. Kouznetsova M, Huang X, Ma J, Lessner L, Carpenter DO. Increased rate of hospitalization for diabetes and residential proximity of hazardous waste sites. Environ Health Perspect. 2007; 115(1):75-79.
47. Hodgson S, Nieuwenhuijsen MJ, Colvile R, Jarup L. Assessment of exposure to mercury from industrial emissions: comparing "distance as a proxy" and dispersion modelling approaches. Occup Environ Med. 2007;64(6):380-388.
48. Sarov B, Bentov Y, Kordysh E, et al. Perinatal mortality and residential proximity to an industrial park. Arch Environ Occup Health. 2008;63(1):17-25.
49. About the National Center for Health Statistics. Available at: http:// www.cdc.gov/nchs/about.htm. Accessed December 9, 2009.
50. National Institutes of Health. HIPAA privacy rule. Available at: http:// privacyruleandresearch.nih.gov. Accessed December 9, 2009.
51. Ness RB. Influence of the HIPAA privacy rule on health research. JAMA. 2007;298(18):2164-2170.
52. US Dept of Education. Family Educational Rights and Privacy Act (FERPA). Available at: http://www.ed.gov/policy/gen/guid/fpco/ferpa/index.html. Accessed December 13, 2009.
53. Association of State and Territorial Health Officials. Position statement-accessing school health information for public health purposes. Available at: http://www.astho.org/pubs/ FERPAPositionStmtFINAL030706.pdf. Accessed December 13, 2009.
54. Kolata G. States and VA at odds on cancer data. New York Times. October 10, 2007. Available at: http://www.nytimes.com/2007/10/10/health/ 10cancer. html. Accessed December 13, 2009.
55. AbdelMalik P, Boulos MNK, Jones R. The perceived impact of location privacy: a Web-based survey of public health perspectives and requirements in the UK and Canada. BMC Public Health. 2008; 8:156.
56. Armstrong MP, Rushton G, Zimmerman DL. Geographically masking health data to preserve confidentiality. Stat Med. 1999;18(5):497-525.
57. Brownstein JS, Cassa CA, Kohane IS, Mandl KD. Reverse geocoding: concerns about patient confidentiality in the display of geospatial health data. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560748/pdf/amia2005- 0905.pdf. Accessed December 13, 2009.
58. Cassa CA, Grannis SJ, Overhage JM, Mandl KD. A context-sensitive approach to anonymizing spatial surveillance data: impact on outbreak detection. J Am Med Inform Assoc. 2006;13(2):160-165.
59. Cassa CA, Wieland SC, Mandl KD. Re-identification of home addresses from spatial locations anonymized by Gaussian skew. Int J Health Geogr. 2008;7:45.
60. Curtis AJ, Mills JW, Leitner M. Spatial confidentiality and GIS: re-engineering mortality locations from published maps about Hurricane Katrina. Int J Health Geogr. 2006;5:44.
61. VanWey LK, Rindfuss RR, Gutmann MP, Entwisle B, Balk DL. Confidentiality and spatially explicit data: concerns and challenges. Proc Natl Acad Sci USA. 2005;102(43):15337-15342.
62. Gonzalez JF Jr, Cox LH. Software for tabular data protection. Stat Med. 2005; 24(4):659-669.